Open AccessGemcitabine and cisplatin treatment over a 3-week versus a 4-week dosing schedule: a randomized trial coducted in Chinese patients with nonsmall cell lung cancer
Author(s) -
Meilin Liao,
Yunzhong Zhu,
Longyun Li,
Huanying Wan,
Shiying Yu,
Belinda J. Hall,
Teena West,
Li Wang
Publication year - 2008
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/00029330-200805020-00006
Subject(s) - gemcitabine , medicine , lung cancer , neutropenia , cisplatin , hazard ratio , toxicity , gastroenterology , randomized controlled trial , chemotherapy , confidence interval